← All stocks

Bristol Myers Squibb

BMY Net selling

CIK 0000014272 #77 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.29M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$2.29M

4 of 4 sales

Net

−$2.29M

−$2.29M against sales at will

By person

16 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Elkins David V

EVP, Chief Financial Officer

—

$1.85M (2)

−$1.85M

159,248

0.0078%

$10.28M

−18.3%

Massacesi Cristian

EVP,Chief Med Offr,Head of Dev

—

$403.50K (1)

−$403.50K

18,748

0.0009%

$1.21M

—

Holzer Phil M

SVP and Controller

—

$33.75K (1)

−$33.75K

16,862

0.0008%

$1.09M

+35.3%

LEUNG SANDRA

EVP, General Counsel

—

364,296

0.0178%

$23.52M

+4.9%

BOERNER CHRISTOPHER S.

Chief Executive Officer

—

146,890

0.0072%

$9.48M

+45.1%

Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

—

83,513

0.0041%

$5.39M

+38.5%

Haller Julia A

Director

—

34,079

0.0017%

$2.20M

+150.2%

Meyers Gregory Scott

EVP, Chief Digital & Tech Off.

—

30,361

0.0015%

$1.96M

+474.4%

Shanahan Karin

EVP, Chief Supply Chain & Ops

—

25,888

0.0013%

$1.67M

+385.2%

Plenge Robert M

EVP, Chief Research Officer

—

21,528

0.0011%

$1.39M

+90.3%

Lenkowsky Adam

EVP, Chief Commercial Officer

—

19,706

0.0010%

$1.27M

+196.3%

Hickey Benjamin

President, RayzeBio Org.

—

16,672

0.0008%

$1.08M

+1,800%

Gallman Cari

EVP, General Counsel

—

13,649

0.0007%

$881.32K

+547.2%

Short Bartie Wendy

EVP, Corporate Affairs

—

12,684

0.0006%

$819.01K

—

Hoch Lynelle

President, Cell Therapy Org.

—

8,210

0.0004%

$530.12K

+375.7%

Poole Ahn Amanda

EVP, Chief People Officer

—

7,094

0.0003%

$458.06K

+192.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Massacesi Cristian

9 Sep 2026

EVP,Chief Med Offr,Head of Dev

Sell

6,249

$64.57

$403.50K

Holzer Phil M

25 Aug 2026

SVP and Controller

Sell

500

$67.50

$33.75K

Elkins David V

1 Apr 2026

EVP, Chief Financial Officer

Sell

4,481

$62.05

$278.05K

Elkins David V

1 Apr 2026

EVP, Chief Financial Officer

Sell

25,519

$61.60

$1.57M

Show all 6 transactions →

What was left out

Form 4 filings counted 62

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 612,032

History held since 7 Sep 2016